These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31598404)
1. Immuno-PET imaging of VEGFR-2 expression in prostate cancer with Li M; Jiang D; Barnhart TE; Cao T; Engle JW; Chen W; Cai W Am J Cancer Res; 2019; 9(9):2037-2046. PubMed ID: 31598404 [TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with Li M; Ehlerding EB; Jiang D; Barnhart TE; Chen W; Cao T; Engle JW; Cai W Am J Transl Res; 2020; 12(5):1862-1872. PubMed ID: 32509182 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging. Novy Z; Janousek J; Barta P; Petrik M; Hajduch M; Trejtnar F J Labelled Comp Radiopharm; 2021 Jun; 64(7):262-270. PubMed ID: 33818828 [TBL] [Abstract][Full Text] [Related]
4. ImmunoPET imaging of tissue factor expression in pancreatic cancer with Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831 [TBL] [Abstract][Full Text] [Related]
5. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer. England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683 [TBL] [Abstract][Full Text] [Related]
6. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants. Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161 [TBL] [Abstract][Full Text] [Related]
7. ImmunoPET imaging of CD38 in murine lymphoma models using Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576 [TBL] [Abstract][Full Text] [Related]
10. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. Ruggiero A; Holland JP; Hudolin T; Shenker L; Koulova A; Bander NH; Lewis JS; Grimm J J Nucl Med; 2011 Oct; 52(10):1608-15. PubMed ID: 21908391 [TBL] [Abstract][Full Text] [Related]
11. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694 [TBL] [Abstract][Full Text] [Related]
12. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab. Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778 [TBL] [Abstract][Full Text] [Related]
13. Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. Jagoda EM; Lang L; Bhadrasetty V; Histed S; Williams M; Kramer-Marek G; Mena E; Rosenblum L; Marik J; Tinianow JN; Merchant M; Szajek L; Paik C; Cecchi F; Raffensperger K; Jose-Dizon JM; Bottaro DP; Choyke P J Nucl Med; 2012 Oct; 53(10):1592-600. PubMed ID: 22917884 [TBL] [Abstract][Full Text] [Related]
14. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides. Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690 [TBL] [Abstract][Full Text] [Related]